About Braeburn
Braeburn is a company based in Philadelphia (United States) founded in 2012.. Braeburn has raised $110 million across 2 funding rounds from investors including New Leaf Venture Partners, RA Capital and Wellington. Braeburn offers products and services including OUD Treatment Products, Advocacy Docuseries, and Volunteer Programs. Braeburn operates in a competitive market with competitors including Avidity Biosciences, Univercells, Indivior, Sutro Biopharma and Vividion Therapeutics, among others.
- Headquarter Philadelphia, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Braeburn Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$110 M (USD)
in 2 rounds
-
Latest Funding Round
$110 M (USD), Debt – Conventional
Jan 10, 2018
-
Investors
New Leaf Venture Partners
& 6 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Braeburn
Braeburn offers a comprehensive portfolio of products and services, including OUD Treatment Products, Advocacy Docuseries, and Volunteer Programs. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Products for managing opioid use disorder and supporting recovery.
Series featuring stories to reduce stigma around addiction.
Programs partnering with organizations for opioid crisis response.
Unlock access to complete
Unlock access to complete
Funding Insights of Braeburn
Braeburn has successfully raised a total of $110M across 2 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $110 million completed in January 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Debt – Conventional — $110.0M
-
First Round
First Round
(08 Jan 2018)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2018 | Amount | Debt – Conventional - Braeburn | Valuation |
investors |
|
| Jan, 2018 | Amount | Series D - Braeburn | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Braeburn
Braeburn has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include New Leaf Venture Partners, RA Capital and Wellington. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Founded Year | Domain | Location | |
|
Stage-agnostic investments in US life sciences are managed.
|
Founded Year | Domain | Location | |
|
Early-stage and late-stage biotech and finance companies are funded.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Braeburn
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Braeburn
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Braeburn Comparisons
Competitors of Braeburn
Braeburn operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Indivior, Sutro Biopharma and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Therapeutics for opioid addiction treatment are developed and commercialized.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
Dental implants and regenerative dentistry products are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Braeburn
Frequently Asked Questions about Braeburn
When was Braeburn founded?
Braeburn was founded in 2012 and raised its 1st funding round 6 years after it was founded.
Where is Braeburn located?
Braeburn is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Who is the current CEO of Braeburn?
Mike Derkacz is the current CEO of Braeburn.
Is Braeburn a funded company?
Braeburn is a funded company, having raised a total of $110M across 2 funding rounds to date. The company's 1st funding round was a Series D of $110M, raised on Jan 08, 2018.
What does Braeburn do?
Braeburn was founded in 2012 in Philadelphia, United States, within the biotechnology sector. Implantable and injectable formulations for treating opioid addiction and chronic pain are developed. The lead product, Probufine, a buprenorphine implant, has been approved by the FDA for opioid dependence. CAM2038 undergoes NDA refiling for opioid dependence and is in phase 3 trials for pain management, delivered subcutaneously via the proprietary FluidCrystal system.
Who are the top competitors of Braeburn?
Braeburn's top competitors include Sutro Biopharma, Avidity Biosciences and Antheia.
What products or services does Braeburn offer?
Braeburn offers OUD Treatment Products, Advocacy Docuseries, and Volunteer Programs.
Who are Braeburn's investors?
Braeburn has 7 investors. Key investors include New Leaf Venture Partners, RA Capital, Wellington, Deerfield, and Rock Springs Capital.